Linking Altered Neuronal and Synaptic Properties to Nicotinic Receptor Alpha5 Subunit Gene Dysfunction: A Translational Investigation in Rat mPFC and Human Cortical Layer 6
Preprint
Abstract
Background: Genetic variation in the α5 nicotinic acetylcholine receptor (nAChR) subunit of mice results in behavioral deficits linked to the prefrontal cortex (PFC). A Single Nucleotide Polymorphisms (SNP) in CHRNA5 imparts a partial loss of function to the α5 subunit-containing (α5*) nAChRs and have been demonstrated to be associated with psychiatric disorders in humans, including schizophrenia, nicotine dependence, cocaine and alcohol addiction. Methods: We performed single cell-electrophysiology combined with morphological reconstructions on layer 6 (L6) excitatory neurons in the medial PFC (mPFC) of wild type (WT) rats (n = 25), rats carrying the human coding polymorphism rs16969968 in Chrna5 (n = 11) and α5 knockout (KO) rats (n = 28). Neuronal and synaptic properties were compared among three rat genotypes. Galantamine was applied to identified L6 neuron populations to specifically boost the nicotinic responses mediated by α5*nAChRs in the rat mPFC and human neocortex (n = 6 patients). Results: Compared with neurons in WT rats, L6 regular spiking (RS) neurons in the α5KO group exhibited altered electrophysiological properties, while those in α5SNP rats remained unchanged. L6 RS neurons in mPFC of α5SNP and α5KO rats differed from WT rats in dendritic morphology, spine density and spontaneous synaptic activity. Galantamine acted as a positive allosteric modulator of α5*nAChRs in RS but not burst spiking (BS) neurons in both rat and human cortical L6. Conclusion: Our findings suggest that dysfunction in the α5 subunit gene leads to aberrant neuronal and synaptic properties, shedding light on the underlying mechanisms of cognitive deficits observed in human populations carrying α5SNPs. They highlight a potential pharmacological target for restoring the relevant behavioral output.Keywords
All Related Versions
- Published version: Translational Psychiatry, 15 (1), 1.
This publication has 98 references indexed in Scilit:
- Nicotinic acetylcholine receptors in attention circuitry: the role of layer VI neurons of prefrontal cortexCellular and Molecular Life Sciences, 2013
- The CHRNA5/A3/B4 Gene Cluster and Tobacco, Alcohol, Cannabis, Inhalants and Other Substance Use Initiation: Replication and New Findings Using Mixture AnalysesBehavior Genetics, 2012
- A double blind, placebo‐controlled pilot study of galantamine augmentation of antidepressant treatment in older adults with major depressionInternational Journal of Geriatric Psychiatry, 2007
- Galantamine for Alzheimer's disease and mild cognitive impairmentCochrane Database of Systematic Reviews, 2006
- Galantamine: a cholinergic patch in the treatment of alcoholism: a randomized, placebo-controlled trialPsychopharmacology, 2005
- Prefrontal cortex in the rat: Projections to subcortical autonomic, motor, and limbic centersJournal of Comparative Neurology, 2005
- Expression of ?5 nicotinic acetylcholine receptor subunit mRNA during hippocampal and cortical developmentJournal of Comparative Neurology, 2004
- Selective Deficits in Prefrontal Cortex Function in Medication-Naive Patients With SchizophreniaArchives of General Psychiatry, 2001
- Cellular basis of working memoryNeuron, 1995
- The distribution of mRNA encoded by a new member of the neuronal nicotinic acetylcholine receptor gene family (α5) in the rat central nervous systemBrain Research, 1990